Quantitative Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Quantitative Investment Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-33,200	Closed	-$52K	–	976
2015 Q3	$52K	Sell	33,200 -31,400	-49%	-$49.2K	﹤0.01%	652
2015 Q2	$109K	Buy	+64,600	New	+$109K	0.02%	415
2014 Q3	–	Sell	-15,700	Closed	-$48K	–	618
2014 Q2	$48K	Sell	15,700 -332,800	-95%	-$1.02M	0.01%	441
2014 Q1	$871K	Buy	348,500 +315,200	+947%	+$788K	0.04%	268
2013 Q4	$165K	Buy	+33,300	New	+$165K	0.02%	529

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Quantitative Investment Management's RXII Position: Q4 2015 in Review

Quantitative Investment Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2015, closing a stake of 33,200 shares — an estimated $52K sold.

Quantitative Investment Management first reported a position in RXII in Q4 2013 and held it in 5 quarters. The position peaked at $871K in Q1 2014. 83 funds tracked by Wall St. Rank hold RXII as of Q4 2015.

Quantitative Investment Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2015 after selling out during the quarter.
Quantitative Investment Management sold 33,200 GALENA BIOPHARMA INC COM shares in Q4 2015, an estimated $52K.
Quantitative Investment Management first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 5 quarters.
Quantitative Investment Management's GALENA BIOPHARMA INC COM position peaked at $871K in Q1 2014.
83 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2015.

Based on Quantitative Investment Management's 13F filing for Q4 2015, filed 8 Feb 2016.